🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a Phase 1 dose-escalation open-label study to determine the r...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-05-04
Trial ID
NCT01138085
Treatments Being Tested
This phase II trial studies how well trametinib and v-akt murine thymoma vi...
Status
Completed
Location
MedStar Georgetown University Hospital
Start Date
2013-10-02
Trial ID
NCT01964924
Treatments Being Tested
This research study is evaluating the combination of two drugs called GSK11...
Status
Terminated
Location
Dana-Farber Cancer Institute
Start Date
2013-10
Trial ID
NCT01958112
Treatments Being Tested
This phase II trial studies how well trametinib and Akt inhibitor GSK214179...
Status
Completed
Location
Foothills Hospital
Start Date
2013-10-30
Trial ID
NCT01989598
Treatments Being Tested
This phase I/II trial studies the side effects and the best dose of uproser...
Status
Completed
Location
USC / Norris Comprehensive Cancer Center
Start Date
2013-10-08
Trial ID
NCT01902173
This phase II trial studies how well trametinib and protein kinase B (Akt) ...
Status
Terminated
Location
University of Chicago Comprehensive Cancer Center
Start Date
2013-10
Trial ID
NCT01907815
Treatments Being Tested
This randomized phase II trial studies how well trametinib with or without ...
Status
Active Not Recruiting
Location
Emory University Hospital/Winship Cancer Institute
Start Date
2013-11-21
Trial ID
NCT01979523
Treatments Being Tested
This is a multicenter phase II clinical study of trametinib in combination ...
Status
Completed
Location
University of California, San Francisco
Start Date
2013-09-10
Trial ID
NCT01941927
Treatments Being Tested
This randomized phase I trial studies how well trametinib with or without G...
Status
Completed
Location
Hartford Hospital
Start Date
2013-09-30
Trial ID
NCT01935973
Treatments Being Tested
The purpose of this study is to explore the potential dose response relatio...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-06-01
Trial ID
NCT01266954
Treatments Being Tested